Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: lapatinib plus oral vinorelbine
Sponsor: National Taiwan University Hospital
Collaborators: GlaxoSmithKline